GOLDEN, Colo. – September 1, 2015 – Today, PharmaJet, the maker of innovative, needle-free injector technology, announced a partnership with ABO Pharmaceuticals, a leader in the flu vaccine distribution market and a worldwide distributor of biological and pharmaceutical products.
Golden, Colo. — August 20, 2015 — The American Pharmacists Association (APhA) has added PharmaJet’s needle-free injection tutorial to their educational curriculum. Posted in early July, the video provides instructions for intramuscular vaccine administration, and is part of: “Patient Care Considerations for Immunizing Pharmacists” in the APhA Pharmacist Injection Certification curriculum.
GOLDEN, Colo. – March 17, 2015 – PharmaJet, the maker of innovative needle-free technology, today announced survey data revealing that healthcare providers (HCPs) would recommend the needle-free injector to colleagues and believed that the use of such a device had the capacity to increase vaccination compliance.
GOLDEN, Colo. – February 26, 2015– Today, PharmaJet, the maker of innovative, needle-free injector technology, announced the release of survey data demonstrating consumer satisfaction with the PharmaJet Needle-Free Injector for seasonal flu vaccinations.
GOLDEN, Colo. – September 30, 2014 – A clinical study published in the August 23, 2014 issue of The Lancet demonstrated that delivery of AFLURIA® (Influenza Vaccine) with the PharmaJet Needle-Free Injector compared favorably to traditional needle and syringe delivery. The U.S. Food and Drug Administration (FDA) recently approved the Stratis® 0.5mL Needle-Free Jet Injector...
KING OF PRUSSIA, Penn. / GOLDEN, Colo. – August 19, 2014 – PharmaJet® Inc., the developer of a needle-free injection technology to administer medications and vaccines to patients, and bioCSL Inc., the maker of AFLURIA® (Influenza Vaccine) today announced the U.S. Food and Drug Administration (FDA) has approved the PharmaJet Stratis® 0.5mL Needle-Free Jet Injector...
GOLDEN, Colo. – Feb. 22, 2013 – PharmaJet Inc. has entered into a collaboration agreement with CureVac GmbH for delivery of CureVac’s mRNA-based vaccine portfolio including targets in oncology and infectious diseases, using the PharmaJet needle-free jet injector platform.
GOLDEN, Colo. – Feb. 20, 2013 – PharmaJet Inc. has become the first and only needle-free injection company to receive Performance, Quality and Safety (PQS) pre-qualified certification from the World Health Organization (WHO).
GOLDEN, Colo. ‐ Nov. 29, 2012 – PharmaJet Inc. has entered into a collaboration with CSL Limited to enable Afluria® influenza vaccine to be delivered with the PharmaJet Stratis® needle‐free jet injector, as soon as the 2013‐2014 flu season.
GOLDEN, Colo. – June 30, 2011 – Now in its third year, Colorado Companies to Watch attracted over 360 nominees. With nearly 100 companies selected as finalists, PharmaJet prevailed along with 49 others to receive the distinction of...